锡斯坦奇 (Cistanche deserticola) 聚糖通过调节肠道屏障功能和肠道微生物群及其代谢物来缓解便秘
Ziqing Yu1, Zhaopeng Zhang2, Chunjie Hu3
1School of Clinical Medicine, Changchun University of Chinese Medicine Changchun 130117, Jilin, China.
American journal of translational research
|December 16, 2024
概括
锡斯坦奇多糖 (CDPS) 通过改善肠道屏障功能和恢复微生物平衡来缓解便秘. 这种传统的中医药增强了肠道健康,减少了炎症,提供了一种自然的方法来控制便秘.
科学领域:
- 药理学和中国传统医学
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
背景情况:
- 便秘是一种常见的疾病,治疗选择有限,往往导致常规药物的依赖和副作用.
- Cistanche deserticola Ma (CDPS) 是一种用于便秘的传统中医药,但其机制需要进一步阐明.
- 洛佩拉胺诱导的便秘模型对于研究治疗干预非常有价值.
研究的目的:
- 为了研究Cistanche多糖 (CDPS) 对小鼠洛佩拉胺诱导的便秘的治疗效果.
- 探索CDPS在缓解便秘方面的潜在药理机制.
- 评估CDPS对肠道屏障功能,炎症和肠道微生物群的影响.
主要方法:
- 建立了洛佩拉胺诱导的便秘小鼠模型.
- 使用ELISA测量血清炎症因子,胃肠道激素和神经递质.
- 通过免疫组织化学和西欧血清来评估肠道紧结的完整性和蛋白质水平.
- 使用16S rRNA测序和代谢学分析肠道微生物社区结构和代谢物含量.
主要成果:
- CDPS显著增强了肠道紧密结合的完整性和改善了粘膜屏障功能.
- CDPS降低了炎症因素的血清水平,并恢复了肠道微生物群的平衡.
- CDPS调节了代谢物概况,增加了有益细菌的丰富性,同时减少了有害细菌.
结论:
- 锡斯坦奇多糖 (CDPS) 在预防和治疗便秘方面具有显著的潜力.
- 通过加强粘膜屏障,调节肠道微生物群,并影响代谢物概况,CDPS发挥其治疗作用.
- 对CDPS的进一步研究为便秘管理提供了一个有前途的自然治疗策略.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
133
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
133
01:22Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
186
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
186
01:17Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
208
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
208
01:20Drugs Affecting GI Tract Motility: Other Laxatives
166
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
166
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
179
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
179